Drug Pricing Archives - Page 22 of 29 - Pacific Research Institute

Drug Pricing

Business & Economics

Pharmaceutical Price Controls Will Not Improve Health Care Outcomes in Illinois

Due to its national implications, last week’s introduction of the Department of Health and Human Services’ (HHS) blueprint on drug prices is garnering all the attention. Despite its importance, HHS’ blueprint should not overshadow the many poor, and even unconstitutional, policy proposals that are occurring at the state level.  For ...
Business & Economics

Creating an Affordable Health Care System Requires More than Rounding Up the Usual Suspects

Health care is becoming less affordable every year. Over the past 10 years, national healthcare expenditures have grown 45 percent, but our economy has grown only 28 percent. This isn’t sustainable; and, solving this problem should be a top policy priority. However, “rounding up the usual suspects,” as Captain Renault ...
Commentary

Just Say No to Drug Imports

A U.S. district court in Montana just imposed a $34 million fine on Canada Drugs, an online pharmacy charged with selling counterfeit medications to unsuspecting Americans. Some of the drugs contained no active ingredients. Canada Drugs isn’t the only online pharmacy that puts patients’ lives in serious jeopardy. The National Association ...
Blog

Single-Payer in California: Slowly, Slowly, Catchy Monkey

For now, California’s progressive politicians have judged single-payer as a bridge too far.  But that doesn’t mean they’ve given up trying to take over health care. As my Canadian mother used to say, “slowly, slowly, catchy monkey” – or be patient. On March 14, Assembly lawmakers released a report by ...
Business & Economics

Report Slams 340B Drug Discount Program

By Tracey Walker The 340B Drug Discount program, designed to give discounted prescription drugs to poor Americans, has not been effective in serving its targeted population, according to a new report. The report, “Addressing the Problems of Abuse in the 340B Drug Pricing Program,” by the Pacific Research Institute, found that the ...
Commentary

Trump Already Making Progress on Making Prescription Drugs Affordable

During Tuesday’s State of the Union address, President Trump pledged to drive down drug prices. That’s a worthy goal. And fortunately, the Trump administration is already pursuing it in a way that protects patients and encourages research and development. Many of the strategies that candidate Trump proposed on the campaign ...
Blog

The Importance of the Banal: The Case of the 340B Program

Most news coverage focuses on the grandiose – repeal of the Affordable Care Act (aka Obamacare), or whether the U.S. should implement a single payer health care system. These existential questions matter of course – a lot. Click on the image above to read Wayne Winegarden’s study, “Addressing the Problems ...
Drug Pricing

Report: 340B Drug Program Rife with Abuse, Profiteering

A program designed to help poor people afford prescription drugs is being used by hospitals to generate easy profits, according to a Pacific Research Institute report. A well-intended program designed to help poor people obtain prescription drugs is riddled with abuse and creates a perverse incentive for healthcare providers to ...
Commentary

Myths and Realities of the Health Care Affordability Problem

According to the five-second rule, you can still eat your food that has fallen on the floor, so long as you picked it up within five seconds. Only, this common perception is bad advice. In reality, if a person eats food that has fallen on a dirty floor, he risks ...
Business & Economics

Well-Meaning Drug Discount Program Encourages Hospitals to Profit Rather than Effectively Serve Poor

A new study released today by the Pacific Research Institute finds that a program to give discounted prescription drugs to poor Americans is riddled with abuse, has created a perverse incentive for providers to profit instead of effectively serve the poor, and is hurting overall health care quality. Click here ...
Business & Economics

Pharmaceutical Price Controls Will Not Improve Health Care Outcomes in Illinois

Due to its national implications, last week’s introduction of the Department of Health and Human Services’ (HHS) blueprint on drug prices is garnering all the attention. Despite its importance, HHS’ blueprint should not overshadow the many poor, and even unconstitutional, policy proposals that are occurring at the state level.  For ...
Business & Economics

Creating an Affordable Health Care System Requires More than Rounding Up the Usual Suspects

Health care is becoming less affordable every year. Over the past 10 years, national healthcare expenditures have grown 45 percent, but our economy has grown only 28 percent. This isn’t sustainable; and, solving this problem should be a top policy priority. However, “rounding up the usual suspects,” as Captain Renault ...
Commentary

Just Say No to Drug Imports

A U.S. district court in Montana just imposed a $34 million fine on Canada Drugs, an online pharmacy charged with selling counterfeit medications to unsuspecting Americans. Some of the drugs contained no active ingredients. Canada Drugs isn’t the only online pharmacy that puts patients’ lives in serious jeopardy. The National Association ...
Blog

Single-Payer in California: Slowly, Slowly, Catchy Monkey

For now, California’s progressive politicians have judged single-payer as a bridge too far.  But that doesn’t mean they’ve given up trying to take over health care. As my Canadian mother used to say, “slowly, slowly, catchy monkey” – or be patient. On March 14, Assembly lawmakers released a report by ...
Business & Economics

Report Slams 340B Drug Discount Program

By Tracey Walker The 340B Drug Discount program, designed to give discounted prescription drugs to poor Americans, has not been effective in serving its targeted population, according to a new report. The report, “Addressing the Problems of Abuse in the 340B Drug Pricing Program,” by the Pacific Research Institute, found that the ...
Commentary

Trump Already Making Progress on Making Prescription Drugs Affordable

During Tuesday’s State of the Union address, President Trump pledged to drive down drug prices. That’s a worthy goal. And fortunately, the Trump administration is already pursuing it in a way that protects patients and encourages research and development. Many of the strategies that candidate Trump proposed on the campaign ...
Blog

The Importance of the Banal: The Case of the 340B Program

Most news coverage focuses on the grandiose – repeal of the Affordable Care Act (aka Obamacare), or whether the U.S. should implement a single payer health care system. These existential questions matter of course – a lot. Click on the image above to read Wayne Winegarden’s study, “Addressing the Problems ...
Drug Pricing

Report: 340B Drug Program Rife with Abuse, Profiteering

A program designed to help poor people afford prescription drugs is being used by hospitals to generate easy profits, according to a Pacific Research Institute report. A well-intended program designed to help poor people obtain prescription drugs is riddled with abuse and creates a perverse incentive for healthcare providers to ...
Commentary

Myths and Realities of the Health Care Affordability Problem

According to the five-second rule, you can still eat your food that has fallen on the floor, so long as you picked it up within five seconds. Only, this common perception is bad advice. In reality, if a person eats food that has fallen on a dirty floor, he risks ...
Business & Economics

Well-Meaning Drug Discount Program Encourages Hospitals to Profit Rather than Effectively Serve Poor

A new study released today by the Pacific Research Institute finds that a program to give discounted prescription drugs to poor Americans is riddled with abuse, has created a perverse incentive for providers to profit instead of effectively serve the poor, and is hurting overall health care quality. Click here ...
Scroll to Top